Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

640
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
640
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

524
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
524
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-intrinsic vulnerability and immune activation cooperate to drive degeneration in a mitochondrial complex I deficiency model of optic neuropathy.

Journal of neuroinflammation·2026
Same author

Cell-Intrinsic Vulnerability and Immune Activation Cooperate to Drive Degeneration in a Mitochondrial Complex I Deficiency Model of Optic Neuropathy.

bioRxiv : the preprint server for biology·2025
Same author

Repurposing Drug Metabolites into Dual β-Adrenergic Receptor-Carbonic Anhydrase Modulators as Potential Tools for Ocular Disorders.

Journal of medicinal chemistry·2025
Same author

Early trigeminal and sensory impairment and lysosomal dysfunction in accurate models of Wolfram syndrome.

Experimental neurology·2024
Same author

The Microphthalmia-Associated Transcription Factor (MITF) and Its Role in the Structure and Function of the Eye.

Genes·2024
Same author

Progressive Cone-Rod Dystrophy and RPE Dysfunction in <i>Mitf</i> Mice.

Genes·2023

Related Experiment Video

Updated: Jul 3, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.8K

Carbonic anhydrase, its inhibitors and vascular function.

Andrea García-Llorca1, Fabrizio Carta2, Claudiu T Supuran2

  • 1Department of Physiology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Frontiers in Molecular Biosciences
|February 13, 2024
PubMed
Summary

Carbonic anhydrase inhibitors (CAIs) affect vascular tone and blood flow, particularly in the eyes and brain. Their vasodilatory mechanisms are being explored, with compound structure influencing efficacy.

Keywords:
blood flowcarbonic anhydraseenzyme isoformsinhibitorsvascular tonevasculature

More Related Videos

Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
07:12

Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry

Published on: January 19, 2020

9.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.3K

Related Experiment Videos

Last Updated: Jul 3, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.8K
Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
07:12

Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry

Published on: January 19, 2020

9.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.3K

Area of Science:

  • Biochemistry
  • Physiology
  • Pharmacology

Background:

  • Carbonic anhydrase (CA) plays a key role in vascular function and tone regulation.
  • Clinically used CA inhibitors (CAIs) primarily treat glaucoma by lowering intraocular pressure.
  • CAIs also influence retinal blood flow and oxygen saturation.

Purpose of the Study:

  • To review the role of CA in vascular function.
  • To emphasize the effects of CA inhibitors (CAIs) on vascular tone.
  • To explore the mechanisms behind CAI-induced vasodilation.

Main Methods:

  • Review of existing studies on CAIs and vascular effects.
  • Analysis of CAI effects on isolated vessel segments.
  • Investigation of structure-activity relationships of CAIs as vasodilators.

Main Results:

  • CAIs demonstrate vasodilatory effects in ocular, cerebral, liver, and kidney vasculature.
  • Vessels in abdominal muscle and stomach are unaffected by CAIs.
  • Sulfonamide-based CAIs directly dilate isolated vessel segments.
  • Coumarin-type CAIs show comparable vasodilation to sulfonamides, suggesting specific isoform involvement.
  • Lipophilicity and membrane permeability of CAIs impact their vasodilatory potency.

Conclusions:

  • CAIs have significant effects on vascular tone and blood flow across various organs.
  • The precise mechanisms of CAI action on vasculature require further elucidation.
  • Understanding CAI structure-activity relationships is crucial for developing targeted vasodilators.